NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.08
+0.12 (1.51%)
Sep 15, 2025, 4:00 PM EDT - Market closed
NeoGenomics Stock Forecast
Stock Price Forecast
The 9 analysts that cover NeoGenomics stock have a consensus rating of "Buy" and an average price target of $12.56, which forecasts a 55.45% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $22.
Price Target: $12.56 (+55.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 3 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 2 |
| Hold | 3 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 9 | 9 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +48.51% | Sep 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6.5 → $11 | Buy | Maintains | $6.5 → $11 | +36.14% | Sep 2, 2025 |
| Needham | Needham | Strong Buy Maintains $8 → $14 | Strong Buy | Maintains | $8 → $14 | +73.27% | Aug 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +36.14% | Aug 4, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | -0.99% | Jul 30, 2025 |
Financial Forecast
Revenue This Year
729.25M
from 660.57M
Increased by 10.40%
Revenue Next Year
802.96M
from 729.25M
Increased by 10.11%
EPS This Year
0.09
from -0.62
EPS Next Year
0.18
from 0.09
Increased by 97.57%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 761.8M | 851.0M | |||
| Avg | 729.3M | 803.0M | |||
| Low | 701.7M | 760.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.3% | 16.7% | |||
| Avg | 10.4% | 10.1% | |||
| Low | 6.2% | 4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.18 | 0.34 | |||
| Avg | 0.09 | 0.18 | |||
| Low | -0.01 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 265.3% | |||
| Avg | - | 97.6% | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.